LUNG has a beta of , meaning it tends to be more sensitive to market movements. LUNG has a correlation of to the broad based SPY ETF. Pulmonx Corp ; Previous Close: ; Open: ; Volume: , ; 3 Month Average Trading Volume: ; Shares Out (Mil): Express News | Pulmonx (akkada.online) has received initial coverage from Lake Street, with a buy rating and a target price of $ BreakingsJun 4 Pulmonx Corp stock price live, this page displays NASDAQ LUNG stock exchange data. View the LUNG premarket stock price ahead of the market session. View Pulmonx Corp. LUNG stock quote prices, financial information, real-time forecasts, and company news from CNN.
LUNG - Pulmonx Corp - Stock screener for investors and traders, financial visualizations. Pulmonx (LUNG) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. Pulmonx Corp LUNG:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date02/15/24 · 52 Week Low · 52 Week. The historical data and Price History for Pulmonx Corp (LUNG) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. Historical daily share price chart and data for Pulmonx since adjusted for splits and dividends. The latest closing stock price for Pulmonx as of. Get the latest Pulmonx Corp (LUNG) real-time quote, historical performance, charts, and other financial information to help you make more informed trading. 27 minutes ago. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. The Pulmonx stock prediction for is currently $ , assuming that Pulmonx shares will continue growing at the average yearly rate as they did in the last. LUNG is trading within a range we consider fairly valued. Price. $ Aug 30, Stock Price Forecast. The 8 analysts with month price forecasts for Pulmonx stock have an average target of , with a low estimate of 10 and a high.
Pulmonx Corporation (LUNG) Q4 Earnings Call Transcript. LUNG earnings call for the period ending December 31, Motley Fool Transcribing | Feb. Pulmonx prices IPO at $19 a share, above proposed price range. Pulmonx, a maker of treatments for lung diseases including emphysema, priced its initial public. Discover historical prices for LUNG stock on Yahoo Finance. View daily, weekly or monthly format back to when Pulmonx Corporation stock was issued. On average, analysts forecast that LUNG's EPS will be -$ for , with the lowest EPS forecast at -$, and the highest EPS forecast at -$ On. In the current month, LUNG has received 8 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. LUNG average Analyst price target in the past 3 months is $ Pulmonx Corporation (akkada.online): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Pulmonx Corporation | Nasdaq: LUNG. Discover real-time Pulmonx Corporation Common Stock (LUNG) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Pulmonx Corporation's stock symbol is LUNG and currently trades under NASDAQ. It's current price per share is approximately $ What are your Pulmonx. LUNG Pulmonx · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. M · Turnover Ratio. % · P/E (Static). Loss.
Institutional Ownership and Shareholders. Pulmonx Corporation (US:LUNG) has institutional owners and shareholders that have filed 13D/G or 13F forms with. 45 minutes ago. Pulmonx NasdaqGS:LUNG Stock Report ; Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 21 Aug, Find the latest historical data for Pulmonx Corporation Common Stock (LUNG) at akkada.online View historical data in a monthly, bi-annual, or yearly format. LUNG Related stocks ; Hims & Hers Health Inc ; INSP, , % ; Inspire Medical Systems Inc ; AXNX, , +%.
LUNG's current price target is $ Learn why top analysts are making this stock forecast for Pulmonx at MarketBeat. Pulmonx Corp Ordinary Shares LUNG. Morningstar Rating. Unlock. Stock XNAS Rating as of May 10, Summary · Chart · News · Price vs Fair Value. Prolung, Inc. is a development-stage medical technology company specializing in predictive analytic, early stage lung cancer risk testing. Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by.
Average Cost Of Auto Insurance In Montana | 20gb Data